C-reactive protein is elevated in schizophrenia
Tài liệu tham khảo
Akanji, 2009, Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients, Psychiatry Res., 169, 56, 10.1016/j.psychres.2008.06.010
Azar, 2011, Comparison of the effects of combination atorvastatin (40mg)+ezetimibe (10mg) versus atorvastatin (40mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent, Am. J. Cardiol., 107, 1571, 10.1016/j.amjcard.2011.01.038
Brown, 2011, The environment and susceptibility to schizophrenia, Prog. Neurobiol., 93, 23, 10.1016/j.pneurobio.2010.09.003
de Leon, 2005, A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors, Schizophr. Res., 76, 135, 10.1016/j.schres.2005.02.010
Diaz, 2010, Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample, Schizophr. Res., 121, 207, 10.1016/j.schres.2010.06.002
Dickerson, 2003, Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia, Arch. Gen. Psychiatry, 60, 466, 10.1001/archpsyc.60.5.466
Dickerson, 2007, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 952, 10.1016/j.pnpbp.2007.02.018
Dickerson, 2008, Association between cognitive functioning, exposure to herpes simplex virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder, Brain Behav. Immun., 22, 1103, 10.1016/j.bbi.2008.04.156
Dickerson, 2010, Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia, Biol. Psychiatry, 68, 100, 10.1016/j.biopsych.2010.03.021
Dieset, 2012, Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein, Schizophr. Res., 140, 169, 10.1016/j.schres.2012.06.040
Fawzi, 2011, C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia, Psychiatry Res., 190, 91, 10.1016/j.psychres.2011.05.010
Fernandez-Egea, 2009, Metabolic profile of antipsychotic-naive individuals with non-affective psychosis, Br. J. Psychiatry, 194, 434, 10.1192/bjp.bp.108.052605
First, 1996
First, 1998
Gejman, 2011, Genetics of schizophrenia: new findings and challenges, Annu. Rev. Genomics Hum. Genet., 12, 121, 10.1146/annurev-genom-082410-101459
Hope, 2009, Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor, Bipolar Disord., 11, 726, 10.1111/j.1399-5618.2009.00757.x
Kay, 1991
Khera, 2005, Race and gender differences in C-reactive protein levels, J. Am. Coll. Cardiol., 46, 464, 10.1016/j.jacc.2005.04.051
Lowe, 2005, Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease, J. Thromb. Haemost., 1618, 10.1111/j.1538-7836.2005.01416.x
Megna, 2011, Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions, Ann. Clin. Psychiatry, 23, 131
Meyer, 2009, Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study, Biol. Psychiatry, 66, 1013, 10.1016/j.biopsych.2009.06.005
Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013
Muller, 2000, The immune system and schizophrenia: an integrative view, Ann. N. Y. Acad. Sci., 917, 456, 10.1111/j.1749-6632.2000.tb05410.x
Osman, 2006, Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease, Vasc. Health Risk Manag., 2, 221, 10.2147/vhrm.2006.2.3.221
Park, 2005, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6, Diabetes Res. Clin. Pract., 69, 29, 10.1016/j.diabres.2004.11.007
Rexrode, 2003, Relationship of total and abdominal adiposity with CRP and IL-6 in women, Ann. Epidemiol., 13, 674, 10.1016/S1047-2797(03)00053-X
Richard, 2012, Schizophrenia and the immune system: pathophysiology, prevention, and treatment, Am. J. Health Syst. Pharm., 69, 757, 10.2146/ajhp110271
Rubin, 1996, Multiple imputation after 18+ years, J. Am. Stat. Assoc., 91, 473, 10.1080/01621459.1996.10476908
Sharpe, 2009, Low-fat oxidation may be a factor in obesity among men with schizophrenia, Acta Psychiatr. Scand., 119, 451, 10.1111/j.1600-0447.2008.01342.x
Sicras-Mainar, 2011, C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice, Eur. Psychiatry, 10.1016/S0924-9338(11)73192-3
Suvisaari, 2011, Inflammation in psychotic disorders: a population-based study, Psychiatry Res., 189, 305, 10.1016/j.psychres.2011.07.006
Tandon, 2008, Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology, Schizophr. Res., 102, 1, 10.1016/j.schres.2008.04.011
The International Schizophrenia Consortium, 2009, Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, 460, 748, 10.1038/nature08185
Wannamethee, 2005, Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, Eur. Heart J., 26, 1765, 10.1093/eurheartj/ehi183
Wener, 2000, The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration, J. Rheumatol., 27, 2351
Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler. Thromb. Vasc. Biol., 19, 972, 10.1161/01.ATV.19.4.972